Potential Benefits of Sodium-Glucose Transporter-2 Inhibitors in the Symptomatic and Functional Status of Patients With Heart Failure: A Systematic Review and Meta-Analysis

This review evaluates the potential benefits of sodium-glucose transporter-2 (SGLT-2) inhibitors on symptom burden/health-related quality of life (HRQoL), functional improvement, hospitalization for heart failure (HHF), cardiovascular mortality (CVM), and all-cause mortality (ACM) in patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhalla, Sushen, AlQabandi, Yousif, Nandula, Savitri Aninditha, Boddepalli, Chinmayi Sree, Gutlapalli, Sai Dheeraj, Lavu, Vamsi Krishna, Abdelwahab Mohamed Abdelwahab, Rana, Huang, Ruimin, Potla, Shanthi, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596091/
https://www.ncbi.nlm.nih.gov/pubmed/36312657
http://dx.doi.org/10.7759/cureus.29579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596091/
https://www.ncbi.nlm.nih.gov/pubmed/36312657
http://dx.doi.org/10.7759/cureus.29579

Ejemplares similares